| Bioactivity | Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers[1][2][3]. |
| Invitro | Fmoc-Val-Cit-PAB-PNP contains peptide sequence degradable by a lysosome enzyme[1].Cathepsin B in the lysosome cleaves the peptide bond between Cit-PAB of dipeptide linkers containing Valine (Val)-citrulline (Cit) and p-aminobenzylalcohol (PAB). When PAB and a drug are binded covalently with carbamate bonds, the drug can be released by hydrolysis after cleavage of the peptide bond between Cit-PAB. Antibody-drug conjugates (ADCs) has been developed using this mechanism[2]. |
| Name | Fmoc-Val-Cit-PAB-PNP |
| CAS | 863971-53-3 |
| Shortening | Fmoc-V-Cit-PAB-PNP |
| Formula | C40H42N6O10 |
| Molar Mass | 766.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |